NYSE:CVS - CVS Health Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$65.26 -0.88 (-1.33 %)
(As of 07/20/2018 04:00 PM ET)
Previous Close$65.26
Today's Range$65.0550 - $65.98
52-Week Range$60.14 - $84.00
Volume6.34 million shs
Average Volume7.74 million shs
Market Capitalization$67.24 billion
P/E Ratio11.06
Dividend Yield3.02%
Beta1
CVS Health logoCVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services. This segment serves employers, insurance companies, unions, government employee groups, health plans, Medicare Part D plans, managed Medicaid plans, plans offered on public and private exchanges, other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Specialty, AccordantCare, SilverScript, Wellpartner, NovoLogix, Coram, Navarro Health Services, and ACS Pharmacy names. As of December 31, 2017, it had 23 retail specialty pharmacy stores, 18 specialty mail order pharmacies and 4 mail order dispensing pharmacies, and 83 branches for infusion and enteral services. The Retail/LTC segment sells prescription drugs, over-the-counter drugs, beauty products and cosmetics, personal care products, convenience foods, seasonal merchandise, and greeting cards, as well as offers photo finishing services. It has 9,803 retail stores in 49 states, the District of Columbia, Puerto Rico, and Brazil primarily under the CVS Pharmacy, CVS, CVS Pharmacy y más, Longs Drugs, Navarro Discount Pharmacy, and Drogaria Onofre names; online retail pharmacy Websites; and 37 onsite pharmacy stores, long-term care pharmacy operations, and retail health care clinics. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1892 and is headquartered in Woonsocket, Rhode Island.

Receive CVS News and Ratings via Email

Sign-up to receive the latest news and ratings for CVS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSE
Industry Drug stores & proprietary stores
Sub-IndustryDrug Retail
SectorRetail/Wholesale
SymbolNYSE:CVS
CUSIP12665010
Phone401-765-1500

Debt

Debt-to-Equity Ratio1.59
Current Ratio2.37
Quick Ratio1.88

Price-To-Earnings

Trailing P/E Ratio11.06
Forward P/E Ratio9.34
P/E Growth0.9

Sales & Book Value

Annual Sales$184.77 billion
Price / Sales0.36
Cash Flow$8.4753 per share
Price / Cash7.70
Book Value$37.21 per share
Price / Book1.75

Profitability

EPS (Most Recent Fiscal Year)$5.90
Net Income$6.62 billion
Net Margins3.59%
Return on Equity17.45%
Return on Assets6.10%

Miscellaneous

Employees246,000
Outstanding Shares1,016,650,000
Market Cap$67,240.99

CVS Health (NYSE:CVS) Frequently Asked Questions

What is CVS Health's stock symbol?

CVS Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CVS."

How often does CVS Health pay dividends? What is the dividend yield for CVS Health?

CVS Health declared a quarterly dividend on Wednesday, July 11th. Investors of record on Wednesday, July 25th will be paid a dividend of $0.50 per share on Wednesday, August 1st. This represents a $2.00 annualized dividend and a dividend yield of 3.06%. The ex-dividend date is Tuesday, July 24th. View CVS Health's Dividend History.

How were CVS Health's earnings last quarter?

CVS Health Corp (NYSE:CVS) released its earnings results on Wednesday, May, 2nd. The pharmacy operator reported $1.48 earnings per share for the quarter, beating analysts' consensus estimates of $1.39 by $0.09. The pharmacy operator earned $45.69 billion during the quarter, compared to analysts' expectations of $45.77 billion. CVS Health had a net margin of 3.59% and a return on equity of 17.45%. The firm's quarterly revenue was up 2.6% on a year-over-year basis. During the same period in the previous year, the firm earned $1.17 earnings per share. View CVS Health's Earnings History.

When is CVS Health's next earnings date?

CVS Health is scheduled to release their next quarterly earnings announcement on Wednesday, August, 8th 2018. View Earnings Estimates for CVS Health.

What guidance has CVS Health issued on next quarter's earnings?

CVS Health issued an update on its FY18 earnings guidance on Wednesday, May, 2nd. The company provided earnings per share guidance of $6.87-7.08 for the period, compared to the Thomson Reuters consensus EPS estimate of $6.45. CVS Health also updated its Q2 guidance to $1.59-1.64 EPS.

What price target have analysts set for CVS?

18 brokers have issued 12-month price targets for CVS Health's shares. Their forecasts range from $68.00 to $99.00. On average, they expect CVS Health's stock price to reach $86.3125 in the next year. This suggests a possible upside of 32.3% from the stock's current price. View Analyst Ratings for CVS Health.

What is the consensus analysts' recommendation for CVS Health?

18 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CVS Health in the last year. There are currently 5 hold ratings, 11 buy ratings and 2 strong buy ratings for the stock, resulting in a consensus recommendation of "Buy."

Are investors shorting CVS Health?

CVS Health saw a increase in short interest in June. As of June 29th, there was short interest totalling 43,844,028 shares, an increase of 0.4% from the June 15th total of 43,662,443 shares. Based on an average daily volume of 9,965,640 shares, the short-interest ratio is presently 4.4 days. Currently, 4.3% of the company's shares are sold short. View CVS Health's Current Options Chain.

Who are some of CVS Health's key competitors?

Who are CVS Health's key executives?

CVS Health's management team includes the folowing people:
  • Mr. Larry J. Merlo, CEO & Director (Age 62)
  • Mr. David M. Denton, Exec. VP & CFO (Age 53)
  • Mr. Jonathan C. Roberts, Exec. VP & COO (Age 62)
  • Mr. Thomas Michael Moriarty, Exec. VP, Chief of Policy & External Affairs Officer and Gen. Counsel (Age 54)
  • Ms. Eva C. Boratto, Exec. VP, Controller & Chief Accounting Officer (Age 51)

Has CVS Health been receiving favorable news coverage?

News stories about CVS stock have trended somewhat positive recently, Accern Sentiment reports. Accern identifies positive and negative news coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. CVS Health earned a media sentiment score of 0.04 on Accern's scale. They also gave media coverage about the pharmacy operator an impact score of 47.22 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company's share price in the next few days.

Who are CVS Health's major shareholders?

CVS Health's stock is owned by a number of of retail and institutional investors. Top institutional investors include Bank of Montreal Can (0.40%), Swedbank (0.20%), Hexavest Inc. (0.13%), Factory Mutual Insurance Co. (0.13%), DnB Asset Management AS (0.12%) and Retirement Systems of Alabama (0.12%). Company insiders that own CVS Health stock include Andrew Sussman, C David Brown II, David M Denton, Eva C Boratto, Helena Foulkes, Jonathan C Roberts, Larry J Merlo, Lisa Bisaccia, Richard J Swift, Thomas M Moriarty and Troyen A Brennan. View Institutional Ownership Trends for CVS Health.

Which institutional investors are selling CVS Health stock?

CVS stock was sold by a variety of institutional investors in the last quarter, including Bank of Montreal Can, NN Investment Partners Holdings N.V., Atwood & Palmer Inc., DnB Asset Management AS, Swedbank, Hartford Investment Management Co., Gateway Investment Advisers LLC and Welch & Forbes LLC. Company insiders that have sold CVS Health company stock in the last year include David M Denton, Helena Foulkes, Jonathan C Roberts, Larry J Merlo, Lisa Bisaccia, Richard J Swift and Thomas M Moriarty. View Insider Buying and Selling for CVS Health.

Which institutional investors are buying CVS Health stock?

CVS stock was purchased by a variety of institutional investors in the last quarter, including Retirement Systems of Alabama, Cornerstone Wealth Management LLC, Howard Capital Management Inc., Meag Munich Ergo Kapitalanlagegesellschaft MBH, Nikko Asset Management Americas Inc., Factory Mutual Insurance Co., Adams Asset Advisors LLC and TNB Financial. View Insider Buying and Selling for CVS Health.

How do I buy shares of CVS Health?

Shares of CVS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is CVS Health's stock price today?

One share of CVS stock can currently be purchased for approximately $65.26.

How big of a company is CVS Health?

CVS Health has a market capitalization of $67.24 billion and generates $184.77 billion in revenue each year. The pharmacy operator earns $6.62 billion in net income (profit) each year or $5.90 on an earnings per share basis. CVS Health employs 246,000 workers across the globe.

How can I contact CVS Health?

CVS Health's mailing address is ONE CVS DR., WOONSOCKET RI, 02895. The pharmacy operator can be reached via phone at 401-765-1500 or via email at [email protected]


MarketBeat Community Rating for CVS Health (NYSE CVS)

Community Ranking:  3.4 out of 5 (star star star)
Outperform Votes:  966 (Vote Outperform)
Underperform Votes:  464 (Vote Underperform)
Total Votes:  1,430
MarketBeat's community ratings are surveys of what our community members think about CVS Health and other stocks. Vote "Outperform" if you believe CVS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CVS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/21/2018 by MarketBeat.com Staff

Featured Article: Short Selling

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.